HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Conflict Of Interest Document For Trial Participants Advocated By FASEB

This article was originally published in The Tan Sheet

Executive Summary

A document written in lay terms explaining a research institution's policies on potential investigator and staff conflicts of interest should be presented to all potential clinical trial subjects, the Federation of American Societies for Experimental Biology suggests.

You may also be interested in...



Financial Conflict Of Interest FDA Surveillance Must Increase - Henney

Increased surveillance of financial conflict of interest is necessary to guard against bias or the perception of bias, FDA Commissioner Jane Henney, MD, indicated at an HHS meeting on human subject protection and financial conflict of interest Aug. 15 at the National Institutes of Health.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS133673

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel